The Association of Clinical Research Professionals
Achieving Global Health Equity Through More Diverse and Inclusive Trials
Health equity requires every moving piece of the healthcare ecosystem, including pharma companies. But ensuring a more equitable and accessible healthcare system starts for pharma at the beginning.
It starts with the HCPs you engage for pre-drug launch and marketing; it starts with the site investigators you recruit; it starts with the location and availability of the study. It comes down to a basic ABC(D) equation. D=diversity.
In this recorded webinar, speakers explore:
- Historically, what has been lacking in clinical trials when it comes to diversity and inclusion
- Why it took federal guidelines to begin to turn the conversation toward pharma and health equity
- How big data can fuel trial diversity and why the data matters as well as a case study
- What the ABC(and D’s) are of clinical trial diversity, equity, access, and inclusion
- Why geography and patient representation matter
Speakers
Alexandra Moens, PharmD, Director of Product Marketing, H1
Stacey Rivkin, VP, Strategic Client Solutions, H1
This program is sponsored by H1.
Program Not Approved for ACRP Contact Hours | Expires November 16, 2025
